Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China
· Delayed Price · Currency is CNY 7.93
+0.04 (0.51%)
Apr 30, 2026, 11:54 AM CST
SHE:300942 Revenue
Shenzhen Bioeasy Biotechnology had revenue of 57.64M CNY in the quarter ending March 31, 2026, with 16.82% growth. This brings the company's revenue in the last twelve months to 271.53M, up 14.51% year-over-year. In the year 2025, Shenzhen Bioeasy Biotechnology had annual revenue of 263.23M with 17.38% growth.
Revenue (ttm)
271.53M
Revenue Growth
+14.51%
P/S Ratio
11.77
Revenue / Employee
565.69K
Employees
480
Market Cap
3.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 263.23M | 38.98M | 17.38% |
| Dec 31, 2024 | 224.25M | -29.86M | -11.75% |
| Dec 31, 2023 | 254.11M | -432.79M | -63.01% |
| Jan 1, 2023 | 686.90M | 89.36M | 14.95% |
| Jan 1, 2022 | 597.54M | 339.08M | 131.20% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Landfar Bio-medicine | 125.47M |
| Shanghai Model Organisms Center | 421.02M |
| Yantai Zhenghai Biotechnology | 347.75M |
| Novoprotein Scientific | 151.51M |
| Jiangsu Sihuan Bioengineering | 344.38M |
| Guangdong VTR Bio-Tech | 832.26M |
| Beijing Kawin Technology Share-Holding | 1.30B |
| Shanghai Shen Lian Biomedical | 288.27M |